Agios Pharmaceuticals (AGIO) is down -13.3%, or -$5.40 to $35.21.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGIO:
- H.C. Wainwright still confident in approval of Agios’ Pyrukynd despite delay
- Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
- Agios Pharmaceuticals falls -14.4%
- Agios Pharmaceuticals provides update on U.S. PDUFA goal date for PYRUKYND
- Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment